← back to search

Ching C. Lau

University of Hong Kong · HK
Area of research
Genetics · Pulmonary and Respiratory Medicine
Research interest
Research interests include Glioma Diagnosis and Treatment, Sarcoma Diagnosis and Treatment, Genomic variations and chromosomal abnormalities, and Cancer-related Molecular Pathways.
h-index
48
citations
13,131
works
213
NIH funding
primary concept
email

Recent publications

Centrosome protein TAX1BP2 mediates STING-dependent immune response and potentiates anti-PD-1 efficacy in hepatocellular carcinoma.
2025cited by 1position: contributordoi
TEC kinase stabilizes PLK4 to promote liver cancer metastasis
Cancer Letters 2022cited by 22position: contributordoi
Centrosomal protein TAX1BP2 inhibits centrosome-microtubules aberrations induced by hepatitis B virus X oncoprotein.
2020cited by 8position: contributordoi
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort
European Journal of Cancer 2019cited by 718position: middledoi
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial
The Lancet Oncology 2016cited by 527position: middledoi
History of chickenpox in glioma risk: a report from the glioma international case–control study (<scp>GICC</scp>)
Cancer Medicine 2016cited by 68position: middledoi
Current state of pediatric sarcoma biology and opportunities for future discovery: A report from the sarcoma translational research workshop
Cancer Genetics 2016cited by 50position: middledoi
NKD2, a negative regulator of Wnt signaling, suppresses tumor growth and metastasis in osteosarcoma
Oncogene 2015cited by 148position: middledoi
Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer
Clinical Cancer Research 2014cited by 1,372position: middledoi
EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment
Annals of Oncology 2014cited by 332position: middledoi
Germline Mutations in Shelterin Complex Genes Are Associated With Familial Glioma
JNCI Journal of the National Cancer Institute 2014cited by 227position: middledoi
Novel somatic and germline mutations in intracranial germ cell tumours
Nature 2014cited by 225position: lastdoi
CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity
Acta Neuropathologica 2014cited by 159position: middledoi
GERM CELL TUMOURS
Neuro-Oncology 2014cited by 26position: middledoi
A gene signature based method for identifying subtypes and subtype-specific drivers in cancer with an application to medulloblastoma
BMC Bioinformatics 2013cited by 306position: middledoi
The Narrow-Spectrum HDAC Inhibitor Entinostat Enhances NKG2D Expression Without NK Cell Toxicity, Leading to Enhanced Recognition of Cancer Cells
Pharmaceutical Research 2013cited by 107position: middledoi
Intravenous injection of oncolytic picornavirus SVV-001 prolongs animal survival in a panel of primary tumor–based orthotopic xenograft mouse models of pediatric glioma
Neuro-Oncology 2013cited by 90position: middledoi
Low penetrance susceptibility to glioma is caused by the TP53 variant rs78378222
British Journal of Cancer 2013cited by 59position: middledoi
Description of selected characteristics of familial glioma patients – Results from the Gliogene Consortium
European Journal of Cancer 2013cited by 40position: middledoi
Insight in glioma susceptibility through an analysis of 6p22.3, 12p13.33-12.1, 17q22-23.2 and 18q23 SNP genotypes in familial and non-familial glioma
Human Genetics 2012cited by 20position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 3 papers (2020–2025)Beatrice Melin · Umeå University2 papers (2013–2016)Georgina Armstrong · Stanford University2 papers (2013–2016)Ryan Merrell · Vanderbilt University2 papers (2013–2016)Elizabeth B. Claus · Brigham and Women's Hospital2 papers (2013–2016)Faith G. Davis · Clark Art Institute2 papers (2013–2016)Sanjay Shete · The University of Texas MD Anderson Cancer Center2 papers (2013–2016)Melissa L. Bondy · Cancer Prevention Institute of California2 papers (2013–2016) · 2 papers (2013–2016)Jonine L. Bernstein · Memorial Sloan Kettering Cancer Center2 papers (2013–2016)Rose Lai · Brigham and Women's Hospital2 papers (2013–2016)Matthew D. Burstein · University Hospitals of Cleveland2 papers (2014–2014)Christopher I. Amos · UNM Comprehensive Cancer Center2 papers (2013–2016)Daniel H. Lachance · Mayo Clinic2 papers (2013–2016)Jill S. Barnholtz‐Sloan · Emory University2 papers (2013–2016)Sara H. Olson · Minneapolis Heart Institute Foundation2 papers (2013–2016)Robert B. Jenkins · Mayo Clinic2 papers (2013–2016)Joellen M. Schildkraut · Institute of Biomedical Sciences, Academia Sinica2 papers (2013–2016)Margaret Wrensch · Neurological Surgery2 papers (2013–2016) · 2 papers (2013–2016)